BioAffinity Technologies' 2023 acquisition Precision Pathology Laboratory Services led to more than $9.4 million in 2024 ...

Clinical and histologic characteristics and survival ... Thus, smoking not only causes lung cancer, but once NSCLC is diagnosed, the prognosis becomes worse. A biological, hormonal, and genetic ...

Last week, readers were most interested in Labcorp's acquisition of assets from MAWD, a CE mark for Roche's mass spec system, and features on Volition and Siemens Healthineers.

A noteworthy case study. What's next for a premenopausal 40-year-old woman in Syria with recurrent hormone receptor-positive ...

Oncologists want definitive guidance on whether patients with resectable NSCLC benefit from immunotherapy before and after ...

Recent research bolsters the case that radiotherapy to treat primary endometrial cancer is associated with an increased risk ...

Nutraceuticals offer potential health benefits, from migraine relief to cognitive support, but safety and regulatory issues ...

LUMINA is an Advanced Minimal Residual Disease Detection Platform for Lung Cancer Harnessing the Power of Multi-omics Biomarkers and AILOS ...

The FastGlioma tool could enable rapid and accurate detection of microscopic tumour infiltration, improving the success of ...

rare type of small cell lung cancer that primarily affects younger people who have never ... Aug. 23, 2024 — A team of researchers has created a digital pathology platform based on artificial ...

AI-driven tools for prescreening patients, predicting responses and outcomes, and guiding patient therapy are maturing and entering the market.

Drug Improves Effectiveness of Radiation for Lung Cancer That Has Spread to the Brain ... 2024 — A team of researchers has created a digital pathology platform based on artificial intelligence.